Skip to content

MedTech Consult

Open bankruptcy
Private limited companyfounded 2020Frans Pepermansstraat 2, 1140 Evere, BelgiumKBO/BCE: BE 0756.543.679

A bankruptcy procedure is open for MedTech Consult according to publications in the Belgian State Gazette; curator: GAUTIER PIRARD.

Summary

The 2024 annual accounts show negative equity (-€458) and a net result of -€1,566.

MedTech ConsultOpen bankruptcy

Are you a creditor?

Open bankruptcy Source: Belgian Official Gazette

If this company owes you money, you are not paid automatically: you file your claim yourself, within the deadline the judgment sets.

The procedure

Court
French-language Enterprise Court of Brussels
Declared bankrupt
3 April 2026
Supervising judge
Reginald D’Hoop De Synghem
Official Gazette
10-04-2026 (pdf) ↗search the document for 2026/115840

Deadlines

Appeal or third-party opposition until
passed on 25 April 2026Fifteen days after the publication in the Official Gazette.art. XX.108 CEL
File the claim in RegSol until
passed on 3 May 2026art. XX.104 and XX.155 CEL
First verification report
passed on 13 May 2026Goods that belong to you, such as those delivered under retention of title, are reclaimed before this day.art. XX.104 and XX.194 CEL
Late claim until
3 April 2027Late, you share only in what has not been paid out yet, and the costs are yours.art. XX.165 CEL

Curator

  • Gautier PirardAvenue Franklin Roose- Velt 51, 1050 Ixellesg.pirard@avocat.be

What to do now

  1. Do not deliver on credit any more without an agreement with the curator.
  2. Gather your documents: invoices, purchase orders, contract, delivery notes and reminders.
  3. File your proof of claim in RegSol (regsol.be), yourself with eID or itsme, or through your lawyer. State principal, interest and costs separately, and any preferential right you hold.
  4. Delivered under retention of title? Reclaim your goods before the first report on the verification of claims.
  5. Ask your accountant about the VAT on the unpaid invoices: in a bankruptcy it can be recovered under conditions.
  6. Follow the file in RegSol: the verification report (admitted or disputed) and the curator's reports appear there.

The deadlines above come from the publication of the judgment. Check them in RegSol before you file anything; a passed deadline no longer applies.

File a claim in RegSol ↗ Watch Follow this bankruptcy: you are alerted when it is closed or reversed.

General information, not legal advice. If in doubt, the curator, your lawyer or your accountant can help.Creditor guide for this company

Embed in an article

Writing about this bankruptcy? Put the card of MedTech Consult in your article: name, enterprise number, its status in the KBO and the latest annual accounts, with a link to this dossier.

Preview
The preview appears here.
  • Stays current: the status follows the register, the figures are those of the latest filed accounts. No Checked score or verdict.
  • Light on your page: one small script and one data request, also answered from a cache; no cookies, no tracking.
  • Where scripts do not run (a newsletter, a feed reader) a plain link remains.

Signals

Four signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024
Equity per financial year
21222324
2021 to 2024 · latest year -€458
raises risk · Register: open bankruptcy
The KBO register records the legal situation: open bankruptcy. This is today's state according to the register itself; the register carries no start date.
KBO · legal situation
raises risk · Open bankruptcy
Active bankruptcy procedure in the Belgisch Staatsblad. Claims are handled by the appointed curator.
Belgian State Gazette
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 21-05-2025, 71 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
not confirmed
2024
71 d early
2023
23 d early
2022
38 d early
2021
79 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 53 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 38% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 14 October 2020, MedTech Consult was incorporated as a Private limited company.1 Total assets went from EUR 17,483 in 2021 to EUR 1,266 in 2024.2 The company was declared bankrupt on 3 April 2026.3

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2021 and 2024
  3. 3Belgian State Gazette, 10-04-2026

Go further with this company

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
-€458
2023 · €1,108
Total assets
€1,266▲ 14.3%
2023 · €1,108
Net result
-€1,566▲ 35.8%
2023 · -€2,439
Working capital
-€458
2022 · €1,855
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 74, Other professional, scientific and technical activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line2021202220232024
Operating result€15,488--€2,286-€2,379▼ 4.1%-€1,412▲ 40.6%
Net result€11,914within the sector's middle half--€2,266below the sector's middle half-€2,439below the sector's middle half▼ 7.6%-€1,566below the sector's middle half▲ 35.8%
Equity€5,814below the sector's middle half-€3,547below the sector's middle half▼ 39.0%€1,108below the sector's middle half▼ 68.8%-€458below the sector's middle half
Total assets€17,483below the sector's middle half-€7,216below the sector's middle half▼ 58.7%€1,108below the sector's middle half▼ 84.6%€1,266below the sector's middle half▲ 14.3%
Debt€11,669-€3,669▼ 68.6%€1,724
Working capital€2,708-€1,855▼ 31.5%-€458
Solvency33.3%within the sector's middle half-49.2%within the sector's middle half▲ 15.9pp
above within below the middle half (P25 to P75) of NACE 74, Other professional, scientific and technical activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€5,000€0€5,000€10,000€15,000Operating result 2021: €15,488€15,488Net result 2021: €11,914€11,914Operating result 2022: -€2,286-€2,286Net result 2022: -€2,266-€2,266Operating result 2023: -€2,379-€2,379Net result 2023: -€2,439-€2,439Operating result 2024: -€1,412-€1,412Net result 2024: -€1,566-€1,5662021202220232024-€3,000-€2,000-€1,000€0Operating result 2022: -€2,286-€2,290Net result 2022: -€2,266-€2,270Operating result 2023: -€2,379-€2,380Net result 2023: -€2,439-€2,440Operating result 2024: -€1,412-€1,410Net result 2024: -€1,566-€1,570202220232024
The operating result stays negative: a loss of €1,412 in 2024 against €2,379 in 2023; the loss shrinks.
Key figures and ratios
2024 value · change against 2023
EBITDA
-€1,134▼
2023 · -€965
Cash flow
-€1,288▼
2023 · -€1,025
Interest coverage
-7.36▼
2023 · -6.27
Debt ≤ 1 year
€1,724
Ratios withheld: a balance sheet total of €1,266 is too small for a meaningful ratio.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 31 lines
Balance sheet Code20232024
Assets
Total assets20/58€1,108€1,266▲
Fixed assets21/28€278-
Tangible fixed assets22/27€278-
Plant, machinery and equipment23€278-
Current assets29/58€830€1,266▲
Amounts receivable within one year40/41€238€891▲
Trade receivables40-€891
Other amounts receivable41€238-
Cash at bank and in hand54/58€592€375▼
Equity and liabilities
Total equity and liabilities10/49€1,108€1,266▲
Equity10/15€1,108-€458▼
Contributions10/11€1,900€1,900=
Profit (loss) carried forward14-€792-€2,358▼
Amounts payable17/49-€1,724
Amounts payable within one year42/48-€1,724
Trade debts44-€891
Suppliers440/4-€891
Other amounts payable47/48-€833
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,414€278▼
Other operating charges640/8€384€387▲
Gross operating margin9900-€581-€747▼
Operating profit (loss)9901-€2,379-€1,412▲
Financial income75/76B€94-
Recurring financial income75€94-
Financial charges65/66B€154€154=
Recurring financial charges65€154€154=
Profit (loss) for the period before taxes9903-€2,439-€1,566▲
Profit (loss) for the period9904-€2,439-€1,566▲
Profit (loss) for the period to be appropriated9905-€2,439-€1,566▲
Appropriation of the result
Profit (loss) to be appropriated9906-€792-€2,358▼
Profit (loss) brought forward from the previous period14P€1,647-€792▼

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2021202220232024Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,136€1,414€1,414€278▼ 80.3%
Other operating charges640/8--€384€387▲ 0.8%
Non-recurring operating charges66A€20,000----
Gross operating margin9900€36,624-€872-€581-€747▼ 28.6%
Operating profit (loss)9901€15,488-€2,286-€2,379-€1,412▲ 40.6%
Financial income75/76B€95€161€94--
Recurring financial income75€95€161€94--
Financial charges65/66B-€141€154€154=
Recurring financial charges65-€141€154€154=
Profit (loss) for the period before taxes9903€15,583-€2,266-€2,439-€1,566▲ 35.8%
Income taxes67/77€3,669----
Profit (loss) for the period9904€11,914-€2,266-€2,439-€1,566▲ 35.8%
Profit (loss) for the period to be appropriated9905€11,914-€2,266-€2,439-€1,566▲ 35.8%
Line2021202220232024Change
Assets
Total assets20/58€17,483€7,216€1,108€1,266▲ 14.3%
Fixed assets21/28€3,106€1,692€278--
Tangible fixed assets22/27€3,106€1,692€278--
Plant, machinery and equipment23€3,106€1,692€278--
Current assets29/58€14,377€5,524€830€1,266▲ 52.5%
Amounts receivable within one year40/41€4,475€4,294€238€891▲ 274%
Trade receivables40---€891-
Other amounts receivable41€4,475€4,294€238--
Cash at bank and in hand54/58€9,902€1,230€592€375▼ 36.7%
Equity and liabilities
Total equity and liabilities10/49€17,483€7,216€1,108€1,266▲ 14.3%
Equity10/15€5,814€3,547€1,108-€458▼ 141%
Contributions10/11€1,900€1,900€1,900€1,900=
Profit (loss) carried forward14€3,914€1,647-€792-€2,358▼ 198%
Amounts payable17/49€11,669€3,669-€1,724-
Amounts payable within one year42/48€11,669€3,669-€1,724-
Trade debts44---€891-
Suppliers440/4---€891-
Taxes, remuneration and social security45€3,669€3,669---
Taxes450/3€3,669€3,669---
Other amounts payable47/48€8,000--€833-
Line2021202220232024Change
Profit (loss) for the period9904€11,914-€2,266-€2,439-€1,566▲ 35.8%
+ Depreciation and write-downs630€1,136€1,414€1,414€278▼ 80.3%
Operating cash flow (approximation)€13,050-€852-€1,025-€1,288▼ 25.7%
Investment in fixed assets (approximation)-€0€0--
Change in cash--€8,672-€638-€217▲ 66.0%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
10-04
Bankruptcy Opening
Tribunal de l’entreprise francophone de Bruxelles · event 03-04-2026
2025
21-05
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
08-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Weakest financial yearnet -€2,439
Net result drops to -€2,439, the lowest in the series.
23-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
13-05
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
SignalFinancial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Evere · 1 establishment unit since 2020
seat establishment The establishment unit on the map
Ground area
65 m²
Building footprint
62 m²
Volume, LiDAR
578 m³
Parcel 21006A0382/00L004, Brussels · tallest building 12.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
MedTech Consult
Frans Pepermansstraat 2, 1140 EvereRetail trade
since 20202.308.904.064
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21006A0382/00L004 Brussels 65 m² 1 · 62 m² 12.5 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Insolvency mandates

1 mandate
Role Name Tenure
Curator GAUTIER PIRARD
AVENUE FRANKLIN ROOSE- VELT 51, 1050 IXELLES
03-04-2026 → present

Similar companies · same sector, comparable size

Of 4,561 companies in sector 74999 we hold annual accounts for 1,935. 231 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded14-10-2020
Fiscal year end31-12
Activities, NACEBEL 2025
74999Other professional, scientific and technical activities
E-invoicing
Reachable via Peppol
Peppol ID 0208:0756543679
Also 9925:BE0756543679
Registered 29-03-2025

The company is no longer active; its Peppol card can remain until its access point withdraws it.

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.